Biotech stocks remain depressed, nearly two years into a dip that has seen the SPDR S&P Biotech ETF drop nearly 50%. The other most-watched exchange-traded fund that tracks the biotech sector, the...
Tag: gilead sciences
Tanking Biotech Stocks Will Mean a Big Year for Deals. Who Could Benefit.
Nearly two years after biotechnology stocks began to tumble, executives at small and midsize companies in the space are finally accepting that share prices aren’t bouncing back anytime soon. With real...
Big Pharma Stocks Are Breaking Out. Here Are Some Winners.
Big pharma stocks are trying to break out to new heights. They have reported more-than-satisfactory earnings and are expecting further progress on new pipelines of drugs. These stocks had been outpe...
Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion
Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...
Gilead Sciences Shares Cross 5% Yield Mark
In trading on Tuesday, shares of Gilead Sciences were yielding above the 5% mark based on its quarterly dividend (annualized to $2.92), with the stock changing hands as low as $57.16 on the day. Divid...
Yes, You Can Get Dividend Yields Around 5%. Here’s How.
If a stock’s yield is around 5%, it could foreshadow a dividend cut or worse. A yield that high, however, doesn’t have to spell doom. Several investors Barron’s spoke to say they can find good opportu...
Due diligence Can Lead Investors to Some Solid Companies With Yields of about 5%.
If a stock’s yield is around 5%, it could foreshadow a dividend cut or worse. A yield that high, however, doesn’t have to spell doom. Several investors Barron’s spoke to say they can find good opportu...